Tag: Paragraph IV certification
180-Day Exclusivity and Authorized Generics: Legal Considerations for Drug Makers
Explore the legal clash between 180-day exclusivity and authorized generics under the Hatch-Waxman Act. Learn how brand strategies impact generic market entry and profitability.